Officers

Matt Patterson Headshot
Chairman

Matt Patterson

Chairman and CEO,
Audentes Therapeutics
Emile Nuwaysir Headshot
Vice Chairman

Emile Nuwaysir

President & Chief Executive Officer,
BlueRock Therapeutics
Amy Butler Headshot
Secretary

Amy Butler

Presint, Biosciences,
Thermo Fisher Scientific
Jeffrey Walsh Headshot
Treasurer

Jeffrey Walsh

Chief Financial and Strategy Officer,
bluebird bio

Board of Directors

Zami Aberman

Chairman & Co-CEO,
Pluristem Therapeutics

Usman Azam

Chief Executive Officer,
Tmunity Therapeutics

Ron Bartek

Co-Founder and President,
Friedreich's Ataxia Research Alliance

Joanne Beck

EVP, Global Pharmaceutical Development and Operations,
Celgene Corporation

James Burns

President and CEO,
Casebia Therapeutics

Amy Butler

Presint, Biosciences,
Thermo Fisher Scientific

Flagg Flanagan

Chairman and CEO,
DiscGenics

Miguel Forte

CEO ,
Zelluna Immunotherapy

Kristen Harrington-Smith

VP and Head, CAR-T US,
Novartis Oncology

Michael Hunt

Chief Financial Officer,
ReNeuron

Paul Laikind

President & CEO,
ViaCyte

Bruce Levine

Founding Director, Clinical Cell and Vaccine Production Facility,
Abramson Cancer Center, University of Pennsylvania

Michael May

President & Chief Executive Officer,
Centre for Commercialization of Regenerative Medicine (CCRM)

Claudia Mitchell

Senior VP, Product and Portfolio Strategy,
Astellas Pharma

Emile Nuwaysir

President & Chief Executive Officer,
BlueRock Therapeutics

Matt Patterson

Chairman and CEO,
Audentes Therapeutics

Isabelle Riviere

Director, Cell Therapy and Cell Engineering Facility,
Memorial Sloan Kettering Cancer Center

Sanjaya Singh

Vice President and Global Head,
Janssen Pharmaceutical Companies of Johnson & Johnson, Janssen Research & Development

Donna Skerrett

Chief Medical Officer,
Mesoblast Limited

Devyn Smith

Chief Operating Officer,
Sigilon Therapeutics

Bob Smith

SVP, Global Gene Therapy Business,
Pfizer

Joe Tarnowski

SVP, Cell and Gene Therapy Platform,
GlaxoSmithKline

Keith Thompson

Chief Executive Officer,
Cell & Gene Therapy Catapult

Arthur Tzianabos

President and CEO,
Homology Medicines

Gil Van Bokkelen

President & CEO,
Athersys

Phil Vanek

General Manager, Cell Therapy Growth Strategies,
GE Healthcare LIfe Sciences

Jeffrey Walsh

Chief Financial and Strategy Officer,
bluebird bio

Susan Washer

President & CEO,
AGTC

Jason Wertheim

Assistant Professor of Surgery - Organ Transplantation, Department of Surgery, Institute for BioNanotechnology in Medicine, Feinberg School of Medicine and Chemistry of Life Processes Institute,
Northwestern University

Executive Committee

Amy Butler

Presint, Biosciences,
Thermo Fisher Scientific

Michael Hunt

Chief Financial Officer,
ReNeuron

Michael May

President & Chief Executive Officer,
Centre for Commercialization of Regenerative Medicine (CCRM)

Emile Nuwaysir

President & Chief Executive Officer,
BlueRock Therapeutics

Matt Patterson

Chairman and CEO,
Audentes Therapeutics

Bob Smith

SVP, Global Gene Therapy Business,
Pfizer

Jeffrey Walsh

Chief Financial and Strategy Officer,
bluebird bio

Phil Vanek

General Manager, Cell Therapy Growth Strategies,
GE Healthcare LIfe Sciences